Spatial repression of PCNA by p53 during kidney development (Q38363218)

2 September 2017

title

Spatial repression of PCNA by p53 during kidney development (English)

1 reference

2 September 2017

Zubaida Saifudeen

1 reference

2 September 2017

Jessica Marks

series ordinal

1 reference

2 September 2017

Hong Du

series ordinal

1 reference

2 September 2017

Samir S El-Dahr

series ordinal

1 reference

2 September 2017

publication date

1 October 2002

1 reference

American Journal of Physiology - Renal Physiology

2 September 2017

published in

1 reference

2 September 2017

volume

283

1 reference

2 September 2017

1 reference

2 September 2017

page(s)

F727-33

1 reference

Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53.

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

Regulation of p53 stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

p53 is a general repressor of RNA polymerase III transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

p53 in embryonic development: maintaining a fine balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

Ontogeny of bradykinin B2 receptors in the rat kidney: implications for segmental nephron maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

Definition of a consensus binding site for p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

A transcriptionally active DNA-binding site for human p53 protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

Morphogen gradient interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

p53 gene is up-regulated during skeletal muscle cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

Tumor spectrum analysis in p53-mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

Transcriptional regulation of the PCNA promoter by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

Transcriptional repression by p53 through direct binding to a novel DNA element

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

21 January 2018

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

Regulation of p53 in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

Analysis of the 5' flanking region of the rat proliferating cell nuclear antigen (PCNA) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

Regulation of the p53 tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

Identification of novel Pax-2 binding sites by chromatin precipitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

Regulation and function of the p53 tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

A role for p53 in terminal epithelial cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

Wild-type human p53 transactivates the human proliferating cell nuclear antigen promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

Interference with p53 protein inhibits hematopoietic and muscle differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

The PAX2 tanscription factor is expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00114.2002

10.1152/AJPRENAL.00114.2002

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference